# Daclizumab Experience in Pediatric Heart Transplant

> **NCT00486057** · — · TERMINATED · sponsor: **Children's Healthcare of Atlanta** · enrollment: 30 (actual)

## Conditions studied

- Congenital Disorders

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00486057
- **Lead sponsor:** Children's Healthcare of Atlanta
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2004-08
- **Primary completion:** —
- **Final completion:** 2007-11
- **Target enrollment:** 30 (ACTUAL)
- **Why stopped:** sufficient data collected for conclusion of retrospective study
- **Last updated:** 2011-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00486057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00486057, "Daclizumab Experience in Pediatric Heart Transplant". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00486057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*